{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:32:08Z","timestamp":1792146728075,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,30]]},"DOI":"10.7759\/cureus.89073","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T17:17:43Z","timestamp":1753895863000},"source":"Crossref","is-referenced-by-count":1,"title":["Cannabis: What We Use, Why It Matters, and When It Is Prescribed (Ethics, Policy, and Practice)"],"prefix":"10.7759","author":[{"given":"Laresh N","family":"Mistry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyas","family":"Neelkanthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saudamini","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himmat","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: State of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti S","year":"2017","unstructured":"Pisanti S, Malfitano AM, Ciaglia E, et al.. Cannabidiol: State of the art and new challenges for therapeutic applications. Pharmacol Ther. 2017, 175:133-50. 10.1016\/j.pharmthera.2017.02.041","journal-title":"Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaim.2024.100911","article-title":"Assessing effects of cannabis on various neuropathologies: A systematic review","volume":"15","author":"Pathak S","year":"2024","unstructured":"Pathak S, Jeyabalan JB, Liu K, et al.. Assessing effects of cannabis on various neuropathologies: A systematic review. J Ayurveda Integr Med. 2024, 15:100911. 10.1016\/j.jaim.2024.100911","journal-title":"J Ayurveda Integr Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam R","year":"2013","unstructured":"Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol. 2013, 64:21-47. 10.1146\/annurev-psych-113011-143739","journal-title":"Annu Rev Psychol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/bs.apha.2017.03.004","article-title":"Cannabis pharmacology: The usual suspects and a few promising leads","volume":"80","author":"Russo EB","year":"2017","unstructured":"Russo EB, Marcu J. Cannabis pharmacology: The usual suspects and a few promising leads. Adv Pharmacol. 2017, 80:67-134. 10.1016\/bs.apha.2017.03.004","journal-title":"Adv Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199662685.003.0001","article-title":"Constituents of Cannabis sativa","author":"ElSohly MA","year":"2014","unstructured":"ElSohly MA, Gul W. Constituents of Cannabis sativa. Handbook of Cannabis. Pertwee R (ed): Oxford University Press, Oxford; 2014. 3-22. 10.1093\/acprof:oso\/9780199662685.003.0001"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.155","article-title":"Corrigendum: New approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"Marzo VD","year":"2018","unstructured":"Marzo VD. Corrigendum: New approaches and challenges to targeting the endocannabinoid system. Nat Rev Drug Discov. 2018, 17:688. 10.1038\/nrd.2018.155","journal-title":"Nat Rev Drug Discov"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158329","article-title":"Cannabinoids drugs and oral health-From recreational side-effects to medicinal purposes: A systematic review","volume":"22","author":"Bellocchio L","year":"2021","unstructured":"Bellocchio L, Inchingolo AD, Inchingolo AM, et al.. Cannabinoids drugs and oral health-From recreational side-effects to medicinal purposes: A systematic review. Int J Mol Sci. 2021, 22:8329. 10.3390\/ijms22158329","journal-title":"Int J Mol Sci"},{"key":"ref8","article-title":"Cannabis","author":"United Nations Office on Drugs and Crime","year":"2010","unstructured":"United Nations Office on Drugs and Crime. Cannabis. World Drug Report. UNODC, Vienna; 2010."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2015.02.008","article-title":"Endocannabinoid signaling at the periphery: 50 years after THC","volume":"36","author":"Maccarrone M","year":"2015","unstructured":"Maccarrone M, Bab I, B\u00edr\u00f3 T, et al.. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci. 2015, 36:277-96. 10.1016\/j.tips.2015.02.008","journal-title":"Trends Pharmacol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2011.0381","article-title":"Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities","volume":"367","author":"Pertwee RG","year":"2012","unstructured":"Pertwee RG. Targeting the endocannabinoid system with cannabinoid receptor agonists: Pharmacological strategies and therapeutic possibilities. Philos Trans R Soc Lond B Biol Sci. 2012, 367:3353-63. 10.1098\/rstb.2011.0381","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system","volume":"19","author":"Zou S","year":"2018","unstructured":"Zou S, Kumar U. Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system. Int J Mol Sci. 2018, 19:833. 10.3390\/ijms19030833","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.54752","article-title":"Assessment of orally administered \u03949-tetrahydrocannabinol when coadministered with cannabidiol on \u03949-tetrahydrocannabinol pharmacokinetics and pharmacodynamics in healthy adults: A randomized clinical trial","volume":"6","author":"Zamarripa CA","year":"2023","unstructured":"Zamarripa CA, Spindle TR, Surujunarain R, et al.. Assessment of orally administered \u03949-tetrahydrocannabinol when coadministered with cannabidiol on \u03949-tetrahydrocannabinol pharmacokinetics and pharmacodynamics in healthy adults: A randomized clinical trial. JAMA Netw Open. 2023, 6:e2254752. 10.1001\/jamanetworkopen.2022.54752","journal-title":"JAMA Netw Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih C","year":"2015","unstructured":"Ibeas Bih C, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ. Molecular targets of cannabidiol in neurological disorders. Neurotherapeutics. 2015, 12:699-730. 10.1007\/s13311-015-0377-3","journal-title":"Neurotherapeutics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.01.003","article-title":"The therapeutic effects of cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report","volume":"49","author":"Abrams DI","year":"2018","unstructured":"Abrams DI. The therapeutic effects of cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. Eur J Intern Med. 2018, 49:7-11. 10.1016\/j.ejim.2018.01.003","journal-title":"Eur J Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5603\/PJNNS.a2022.0015","article-title":"Cannabis and cannabinoids: Pharmacology and therapeutic potential","volume":"56","author":"\u015amiarowska M","year":"2022","unstructured":"\u015amiarowska M, Bia\u0142ecka M, Machoy-Mokrzy\u0144ska A. Cannabis and cannabinoids: Pharmacology and therapeutic potential. Neurol Neurochir Pol. 2022, 56:4-13. 10.5603\/PJNNS.a2022.0015","journal-title":"Neurol Neurochir Pol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow ND","year":"2014","unstructured":"Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014, 370:2219-27. 10.1056\/NEJMra1402309","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2023.0223","article-title":"Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs","volume":"120","author":"Herdegen T","year":"2023","unstructured":"Herdegen T, Cascorbi I. Drug interactions of tetrahydrocannabinol and cannabidiol in cannabinoid drugs. Dtsch Arztebl Int. 2023, 120:833-40. 10.3238\/arztebl.m2023.0223","journal-title":"Dtsch Arztebl Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2174\/1389200217666151210142051","article-title":"Cannabinoids and cytochrome P450 interactions","volume":"17","author":"Zendulka O","year":"2016","unstructured":"Zendulka O, Dovrt\u011blov\u00e1 G, Noskov\u00e1 K, Turjap M, \u0160ulcov\u00e1 A, Hanu\u0161 L, Ju\u0159ica J. Cannabinoids and cytochrome P450 interactions. Curr Drug Metab. 2016, 17:206-26. 10.2174\/1389200217666151210142051","journal-title":"Curr Drug Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-021-00073-1","article-title":"Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: Results of a modified Delphi process","volume":"3","author":"Bhaskar A","year":"2021","unstructured":"Bhaskar A, Bell A, Boivin M, et al.. Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: Results of a modified Delphi process. J Cannabis Res. 2021, 3:22. 10.1186\/s42238-021-00073-1","journal-title":"J Cannabis Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/medicines6010003","article-title":"Medicinal cannabis-Potential drug interactions","volume":"6","author":"Alsherbiny MA","year":"2018","unstructured":"Alsherbiny MA, Li CG. Medicinal cannabis-Potential drug interactions. Medicines (Basel). 2018, 6:3. 10.3390\/medicines6010003","journal-title":"Medicines (Basel)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192215261","article-title":"Associations between oral health and cannabis use among adolescents and young adults: Implications for orthodontists","volume":"19","author":"Le A","year":"2022","unstructured":"Le A, Khoo E, Palamar JJ. Associations between oral health and cannabis use among adolescents and young adults: Implications for orthodontists. Int J Environ Res Public Health. 2022, 19:15261. 10.3390\/ijerph192215261","journal-title":"Int J Environ Res Public Health"},{"key":"ref22","unstructured":"U.S. Food and Drug Administration. FDA and Cannabis. Research and Drug Approval Process. (2018). Accessed: February 24, 2023: https:\/\/www.fda.gov\/news-events\/public-health-focus\/fda-and-cannabis-research-and-drug-approval-process."},{"key":"ref23","article-title":"Cannabis-based medicine and its relevance to dental pain management","author":"Hargreaves KM","year":"2021","unstructured":"Hargreaves KM, Cohen S, Berman LH. Cannabis-based medicine and its relevance to dental pain management. Cohen\u2019s Pathways of the Pulp, 11th ed. Hargreaves KM, Berman LH (ed): Elsevier, St. Louis, MO; 2021. 999-1009."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2008.11.010","article-title":"Cannabidiol decreases bone resorption by inhibiting RANK\/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats","volume":"9","author":"Napimoga MH","year":"2009","unstructured":"Napimoga MH, Benatti BB, Lima FO, et al.. Cannabidiol decreases bone resorption by inhibiting RANK\/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int Immunopharmacol. 2009, 9:216-22. 10.1016\/j.intimp.2008.11.010","journal-title":"Int Immunopharmacol"},{"key":"ref25","article-title":"Marijuana and cannabinoid use in clinical oral and maxillofacial surgery: A scoping review","volume":"1","author":"Tang LY","year":"2022","unstructured":"Tang LY, Emery AR, Wang J. Marijuana and cannabinoid use in clinical oral and maxillofacial surgery: A scoping review. J Oral Maxillofac Anesth. 2022, 1:6.","journal-title":"J Oral Maxillofac Anesth"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.joen.2024.10.010","article-title":"Effect of preoperative oral cannabidiol-rich cannabis extract on anxiety and postoperative pain after endodontic treatment: A double-blind randomized clinical trial","volume":"50","author":"de Andrade Silva S","year":"2024","unstructured":"de Andrade Silva S, Velozo C, de Almeida Souto Montenegro L, de Sousa WV, da Cunha Isaltino M, de F\u00e1tima Formiga Melo Diniz M, de Albuquerque DS. Effect of preoperative oral cannabidiol-rich cannabis extract on anxiety and postoperative pain after endodontic treatment: A double-blind randomized clinical trial. J Endod. 2024, 50:1698-704. 10.1016\/j.joen.2024.10.010","journal-title":"J Endod"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-023-03810-5","article-title":"The role of cannabinoid receptor 2 in bone remodeling during orthodontic tooth movement","volume":"24","author":"Fan DY","year":"2024","unstructured":"Fan DY, Zhai HY, Zhao Y, Qiao X, Zhu DC, Liu HJ, Liu C. The role of cannabinoid receptor 2 in bone remodeling during orthodontic tooth movement. BMC Oral Health. 2024, 24:23. 10.1186\/s12903-023-03810-5","journal-title":"BMC Oral Health"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1834-7819.2005.tb00343.x","article-title":"General and oral health implications of cannabis use","volume":"50","author":"Cho CM","year":"2005","unstructured":"Cho CM, Hirsch R, Johnstone S. General and oral health implications of cannabis use. Aust Dent J. 2005, 50:70-4. 10.1111\/j.1834-7819.2005.tb00343.x","journal-title":"Aust Dent J"},{"key":"ref29","article-title":"Orofacial Pain and Headache","author":"Sharav Y","year":"2008","unstructured":"Sharav Y, Benoliel R. Orofacial Pain and Headache. Elsevier Health Sciences, Amsterdam; 2008."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2013.00001","article-title":"Proof of concept trial of dronabinol in obstructive sleep apnea","volume":"4","author":"Prasad B","year":"2013","unstructured":"Prasad B, Radulovacki MG, Carley DW. Proof of concept trial of dronabinol in obstructive sleep apnea. Front Psychiatry. 2013, 4:1. 10.3389\/fpsyt.2013.00001","journal-title":"Front Psychiatry"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kei183","article-title":"Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis","volume":"45","author":"Blake DR","year":"2006","unstructured":"Blake DR, Robson P, Ho M, Jubb RW, McCabe CS. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Rheumatology (Oxford). 2006, 45:50-2. 10.1093\/rheumatology\/kei183","journal-title":"Rheumatology (Oxford)"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000002110","article-title":"Selective cannabinoids for chronic neuropathic pain: A systematic review and meta-analysis","volume":"125","author":"Meng H","year":"2017","unstructured":"Meng H, Johnston B, Englesakis M, Moulin DE, Bhatia A. Selective cannabinoids for chronic neuropathic pain: A systematic review and meta-analysis. Anesth Analg. 2017, 125:1638-52. 10.1213\/ANE.0000000000002110","journal-title":"Anesth Analg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1080\/14659891.2018.1508518","article-title":"Oral health implications of increased cannabis use among older adults: Another public health concern?","volume":"24","author":"Le A","year":"2019","unstructured":"Le A, Palamar JJ. Oral health implications of increased cannabis use among older adults: Another public health concern?. J Subst Use. 2019, 24:61-5. 10.1080\/14659891.2018.1508518","journal-title":"J Subst Use"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-019-0906-y","article-title":"A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers","volume":"20","author":"Philpot LM","year":"2019","unstructured":"Philpot LM, Ebbert JO, Hurt RT. A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. BMC Fam Pract. 2019, 20:17. 10.1186\/s12875-019-0906-y","journal-title":"BMC Fam Pract"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2011.00313.x","article-title":"Barriers and facilitators to cannabis treatment","volume":"31","author":"Gates P","year":"2012","unstructured":"Gates P, Copeland J, Swift W, Martin G. Barriers and facilitators to cannabis treatment. Drug Alcohol Rev. 2012, 31:311-9. 10.1111\/j.1465-3362.2011.00313.x","journal-title":"Drug Alcohol Rev"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2021.102675","article-title":"Medical cannabis education among healthcare trainees: A scoping review","volume":"58","author":"Zolotov Y","year":"2021","unstructured":"Zolotov Y, Metri S, Calabria E, Kogan M. Medical cannabis education among healthcare trainees: A scoping review. Complement Ther Med. 2021, 58:102675. 10.1016\/j.ctim.2021.102675","journal-title":"Complement Ther Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.01.016","article-title":"Ethical issues in medical cannabis use","volume":"49","author":"Sagy I","year":"2018","unstructured":"Sagy I, Peleg-Sagy T, Barski L, Zeller L, Jotkowitz A. Ethical issues in medical cannabis use. Eur J Intern Med. 2018, 49:20-2. 10.1016\/j.ejim.2018.01.016","journal-title":"Eur J Intern Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-0558","article-title":"Ethical implications for providers regarding cannabis use in children with autism spectrum disorders","volume":"143","author":"Duvall SW","year":"2019","unstructured":"Duvall SW, Lindly O, Zuckerman K, Msall ME, Weddle M. Ethical implications for providers regarding cannabis use in children with autism spectrum disorders. Pediatrics. 2019, 143:e20180558. 10.1542\/peds.2018-0558","journal-title":"Pediatrics"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714631","article-title":"Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome","volume":"378","author":"Devinsky O","year":"2018","unstructured":"Devinsky O, Patel AD, Cross JH, et al.. Effect of cannabidiol on drop seizures in the Lennox-Gastaut syndrome. N Engl J Med. 2018, 378:1888-97. 10.1056\/NEJMoa1714631","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.01.004","article-title":"Practical considerations in medical cannabis administration and dosing","volume":"49","author":"MacCallum CA","year":"2018","unstructured":"MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018, 49:12-9. 10.1016\/j.ejim.2018.01.004","journal-title":"Eur J Intern Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/adj.12934","article-title":"Cannabinoid therapeutics in orofacial pain management: A systematic review","volume":"67","author":"Votrubec C","year":"2022","unstructured":"Votrubec C, Tran P, Lei A, Brunet Z, Bean L, Olsen BW, Sharma D. Cannabinoid therapeutics in orofacial pain management: A systematic review. Aust Dent J. 2022, 67:314-27. 10.1111\/adj.12934","journal-title":"Aust Dent J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.25258\/ijpqa.15.4.8","article-title":"Assessment of the common practices for writing dental prescriptions among different departments of a dental college and hospital in India: A retrospective study","volume":"15","author":"Jawdekar A","year":"2024","unstructured":"Jawdekar A, Mistry L, Goel S, Tripathy M, Bhattacharjee M, Sreenivasan V. Assessment of the common practices for writing dental prescriptions among different departments of a dental college and hospital in India: A retrospective study.  Int J Pharm Qual Assur. 2024, 15:2151-6. 10.25258\/ijpqa.15.4.8","journal-title":"Int J Pharm Qual Assur"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/s41407-025-2927-9","article-title":"The clinical implications of cannabis use in dentistry","volume":"12","author":"Dave M","year":"2025","unstructured":"Dave M, Patel N. The clinical implications of cannabis use in dentistry. BDJ Team. 2025, 12:137-9. 10.1038\/s41407-025-2927-9","journal-title":"BDJ Team"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/387847-cannabis-what-we-use-why-it-matters-and-when-it-is-prescribed-ethics-policy-and-practice","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T17:17:45Z","timestamp":1753895865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/387847-cannabis-what-we-use-why-it-matters-and-when-it-is-prescribed-ethics-policy-and-practice"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.89073","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}